ATE283697T1 - Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort - Google Patents

Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort

Info

Publication number
ATE283697T1
ATE283697T1 AT01903767T AT01903767T ATE283697T1 AT E283697 T1 ATE283697 T1 AT E283697T1 AT 01903767 T AT01903767 T AT 01903767T AT 01903767 T AT01903767 T AT 01903767T AT E283697 T1 ATE283697 T1 AT E283697T1
Authority
AT
Austria
Prior art keywords
praebiotic
boosting
adjuvant
immune response
carbohydrate formulation
Prior art date
Application number
AT01903767T
Other languages
English (en)
Inventor
Ferdinand Haschke
Anne-Lise Carrie
Zdenek Kratky
Harriet Link-Amster
Florence Rochat
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE283697T1 publication Critical patent/ATE283697T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Grain Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01903767T 2000-03-01 2001-02-14 Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort ATE283697T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200735 2000-03-01
PCT/EP2001/001627 WO2001064225A1 (en) 2000-03-01 2001-02-14 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Publications (1)

Publication Number Publication Date
ATE283697T1 true ATE283697T1 (de) 2004-12-15

Family

ID=8171132

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01903767T ATE283697T1 (de) 2000-03-01 2001-02-14 Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort

Country Status (22)

Country Link
US (2) US20030040492A1 (de)
EP (1) EP1261355B1 (de)
JP (1) JP4838477B2 (de)
KR (1) KR20020081375A (de)
CN (1) CN1243551C (de)
AR (1) AR027968A1 (de)
AT (1) ATE283697T1 (de)
AU (2) AU3174601A (de)
BR (1) BR0108828A (de)
CA (1) CA2400969C (de)
DE (1) DE60107544T2 (de)
ES (1) ES2232591T3 (de)
HK (1) HK1051650A1 (de)
HU (1) HUP0204546A3 (de)
IL (1) IL151280A0 (de)
MX (1) MXPA02008447A (de)
NO (1) NO20024011D0 (de)
PL (1) PL365136A1 (de)
PT (1) PT1261355E (de)
UA (1) UA73763C2 (de)
WO (1) WO2001064225A1 (de)
ZA (1) ZA200207849B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6319252B1 (en) 1999-07-23 2001-11-20 Mcdevitt Dennis System and method for attaching soft tissue to bone
KR20020043078A (ko) * 2000-12-01 2002-06-08 한인규 올리고당이 포함된 복합생균제
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
PT1638416E (pt) * 2003-06-23 2013-07-08 Nestec Sa Utilização de uma fórmula nutricional para função de barreira intestinal óptima
US20050118299A1 (en) * 2003-12-01 2005-06-02 The Iams Company Companion animal compositions comprising short chain oligofructose
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
US20050119222A1 (en) 2003-12-01 2005-06-02 The Iams Company Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
US20100055083A1 (en) * 2006-10-18 2010-03-04 Ray Edward Kowalski Encapsulation of heat and moisture sensitive substances
DE102007008664B4 (de) * 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
WO2009027039A1 (en) * 2007-08-24 2009-03-05 Barry Callebaut Ag Process and confectionery product produced thereby
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
PL2285387T3 (pl) 2008-06-13 2016-03-31 Nutricia Nv Odżywka do zapobiegania infekcjom
EP2293802A4 (de) * 2008-06-25 2011-11-09 Ritter Pharmaceuticals Inc Lactosezusammensetzungen mit reduziertem lactosegehalt
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8425955B2 (en) * 2009-02-12 2013-04-23 Mead Johnson Nutrition Company Nutritional composition with prebiotic component
JP2012518635A (ja) 2009-02-24 2012-08-16 リター ファーマシューティカルズ インコーポレイテッド プレバイオティック製剤および使用方法
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
CN106890329A (zh) 2009-07-15 2017-06-27 N·V·努特里奇亚 用于刺激免疫系统的不可消化低聚糖的混合物
ES2525565T3 (es) 2009-07-15 2014-12-26 N.V. Nutricia Fucosilactosa como oligasacárido no digerible idéntico a la leche humana para tratar y/o prevenir infecciones víricas
BR112012011294B1 (pt) 2009-11-12 2018-03-20 Nestec S.A. Composição nutricional para administração a um indivíduo
EP2563372A4 (de) 2010-04-28 2013-10-02 Ritter Pharmaceuticals Inc Präbiotische formulierungen und verwendungsverfahren dafür
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
US20150086587A1 (en) * 2012-03-28 2015-03-26 Kansas State University Research Foundation Vaccine adjuvant
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
CN103330935A (zh) * 2013-06-17 2013-10-02 中山大学 果糖作为疫苗佐剂的应用
WO2017021413A1 (en) * 2015-08-04 2017-02-09 Südzucker AG Prophylactic use of inulin against sinusitis
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
MX2020002659A (es) 2017-09-08 2020-09-09 Evelo Biosciences Inc Vesiculas extracelulares bacterianas.
KR20200053532A (ko) * 2017-09-08 2020-05-18 에벨로 바이오사이언시즈, 인크. 프레보텔라로부터의 세포외 소포
JP7469037B2 (ja) * 2019-02-28 2024-04-16 森永乳業株式会社 発酵乳
CN111529703B (zh) * 2020-06-17 2023-09-15 湖南循天然营养有限公司 一种组合物及其制备方法与在制备免疫佐剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725683B2 (ja) * 1985-10-31 1995-03-22 ザ オ−ストラリアン ナシヨナル ユニバ−シテイ− 免疫治療方法
US5422346A (en) 1988-01-06 1995-06-06 California Natural Products Instant dried dahlia inulin juice and its method of production and usage
DE4341780A1 (de) * 1993-12-08 1995-06-14 Suedzucker Ag Hydrierte Fructooligosaccharide
EP0692252B1 (de) * 1994-06-14 2001-04-04 "Raffinerie Tirlemontoise", société anonyme: Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel
EP0856259B1 (de) * 1996-12-23 1998-08-12 SITIA-YOMO S.p.A. Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome

Also Published As

Publication number Publication date
AU2001231746B2 (en) 2004-12-23
EP1261355B1 (de) 2004-12-01
CA2400969A1 (en) 2001-09-07
HUP0204546A3 (en) 2003-10-28
AR027968A1 (es) 2003-04-16
NO20024011L (no) 2002-08-22
EP1261355A1 (de) 2002-12-04
NO20024011D0 (no) 2002-08-22
CN1422158A (zh) 2003-06-04
PT1261355E (pt) 2005-02-28
AU3174601A (en) 2001-09-12
JP4838477B2 (ja) 2011-12-14
CA2400969C (en) 2011-04-19
US7101553B2 (en) 2006-09-05
HK1051650A1 (en) 2003-08-15
MXPA02008447A (es) 2002-12-13
DE60107544T2 (de) 2005-12-15
HUP0204546A2 (en) 2003-05-28
JP2003533438A (ja) 2003-11-11
CN1243551C (zh) 2006-03-01
ES2232591T3 (es) 2005-06-01
BR0108828A (pt) 2002-12-10
DE60107544D1 (de) 2005-01-05
AU2001231746C1 (en) 2005-10-06
WO2001064225A1 (en) 2001-09-07
PL365136A1 (en) 2004-12-27
US20030040492A1 (en) 2003-02-27
IL151280A0 (en) 2003-04-10
UA73763C2 (en) 2005-09-15
KR20020081375A (ko) 2002-10-26
US20040191234A1 (en) 2004-09-30
ZA200207849B (en) 2003-12-30

Similar Documents

Publication Publication Date Title
ATE283697T1 (de) Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort
DE69907420D1 (de) Zyklische pro-duftverbindungen die die geruchrohstoffalkohol freisetzungsstufe ändern
PT1139764E (pt) Composicao adjuvante
DK1265633T3 (da) Vaccineadjuvans
ITBO990289A0 (it) Apparecchiatura per la realizzazione di cornici rettangolari .
DE60101126D1 (de) Tintenstrahlaufzeichnungselement
IT1307196B1 (it) Dispositivo di comando per idropulitrici o simili
FIU20010274U0 (fi) Imulaite
ATE94417T1 (de) Chip fuer spieltische.
GB2364642B (en) Compositions for enhancing the immune response
DE60102606D1 (de) Tintenstrahlaufzeichnungselement
DE60014306D1 (de) Tintenstrahlaufzeichnungselement
ITMI20001695A0 (it) Procedimento per la preparazione di composizioni organico-sili-coniche.
FI20010247A0 (fi) Imulaite
NO20032086L (no) Adjuvans kombinasjonsformuleringer
DE60101705D1 (de) Tintenstrahlaufzeichnungselement
DE69201298T2 (de) Klebemittelzusammensetzungen.
ITBO990458A0 (it) Apparecchiatura per la realizzazione di cornici rettangolari .
DK1261355T3 (da) Carbohydratformulering (præbiotisk adjuvans) til forstærkning af immunresponset
DE60111997D1 (de) Tintenstrahlaufzeichnungselement
ATE395352T1 (de) 17.alpha.-hydroxy-14.beta.-steroide mit hormonaler wirkung
ITMI20001600A1 (it) Procedimento per la preparazione di 5-amino-4-alo-3-alchil isossazoli.
ES1016586Y (es) Nicho funerario.
DE60237252D1 (de) Bildaufzeichnungsgerät
FR2824262B1 (fr) Le slip preservatif

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1261355

Country of ref document: EP

REN Ceased due to non-payment of the annual fee